Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
812.60    9.80 (1.22%)
Bid:
806.40
Ask:
806.80
Spread: 0.40 (0.05%)
Market Cap: £7.32b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Share buy-back programme

12 Mar 2020 07:00

RNS Number : 8445F
Sage Group PLC
12 March 2020
 

Share buy-back programme

12 March 2020

Further to the announcement made on 11 March 2020, The Sage Group plc ("Sage") today announces the commencement of its share buy-back programme.

Sage has entered into non-discretionary arrangements with its joint corporate brokers, Citigroup Global Markets Limited and Morgan Stanley & Co. International plc (together the "Brokers"), in relation to the purchase by the Brokers, acting as principals, of ordinary shares of Sage (the "Shares"). These arrangements will commence on 12 March 2020, are expected to end no later than 13 January 2021, and will be for a value of up to £250 million.

The Brokers will make trading decisions in relation to Shares purchased under the buy-back programme independently of, and uninfluenced by, Sage. The Brokers will make a simultaneous on-sale of such Shares to Sage, and all Shares repurchased will be held in treasury and used to meet obligations arising from share option programmes, or other allocations of shares, to employees or directors.

Any purchases of Shares contemplated by this announcement will be carried out on the London Stock Exchange and/or other recognised investment exchange(s), and will be effected within certain pre-set parameters. These arrangements are in accordance with Sage's general authority to repurchase up to 109,137,735 Shares granted at its 2020 Annual General Meeting, Chapter 12 of the Listing Rules and those provisions of Market Abuse Regulation 596/2014/EU dealing with buy-back programmes.

 

Enquiries

The Sage Group plc +44(0) 191 294 3457

Jonathan Howell, Chief Financial Officer

James Sandford, Investor Relations

Amy Lawson, Media

FTI Consulting +44(0) 20 3727 1000

Charles Palmer

Dwight Burden

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCGPUCPWUPUGRG
Date   Source Headline
30th Jun 20239:48 amRNSDirector/PDMR Shareholding
27th Jun 20235:16 pmRNSDirector/PDMR Shareholding
21st Jun 20239:00 amRNSDirector/PDMR Shareholding
6th Jun 202312:02 pmRNSBlock listing Interim Review
31st May 20234:55 pmRNSHolding(s) in Company
31st May 20234:50 pmRNSTotal Voting Rights
30th May 202310:10 amRNSDirector/PDMR Shareholding
19th May 20234:58 pmRNSDirector/PDMR Shareholding
19th May 20234:45 pmRNSHolding(s) in Company
17th May 20237:00 amRNSResults for the six months to 31 March 2023
28th Apr 20233:30 pmRNSTotal Voting Rights
31st Mar 20232:11 pmRNSDirector/PDMR Shareholding
31st Mar 202312:40 pmRNSTotal Voting Rights
27th Mar 20231:40 pmRNSDirector/PDMR Shareholding
6th Mar 20234:42 pmRNSHolding(s) in Company
28th Feb 20231:50 pmRNSTotal Voting Rights
17th Feb 20235:22 pmRNSDirector/PDMR Shareholding
17th Feb 20235:02 pmRNSDirector/PDMR Shareholding
14th Feb 20233:59 pmRNSDirector/PDMR Shareholding
13th Feb 20236:16 pmRNSPublication of Final Terms
9th Feb 20239:32 amRNSDirector/PDMR Shareholding
7th Feb 20239:46 amRNSDirector/PDMR Shareholding
3rd Feb 202312:14 pmRNSDirector Declaration
2nd Feb 20233:31 pmRNSResult of AGM
2nd Feb 20239:57 amRNSDirector Declaration
31st Jan 20233:35 pmRNSSage: Publication of Base Prospectus
31st Jan 20233:00 pmRNSTotal Voting Rights
23rd Jan 20234:58 pmRNSDirector/PDMR Shareholding
19th Jan 20237:00 amRNSTrading Update for the 3 months ended 31 Dec 2022
30th Dec 202211:15 amRNSTotal Voting Rights
15th Dec 202211:21 amRNSDirector/PDMR Shareholding
8th Dec 20225:40 pmRNSDirector/PDMR Shareholding
8th Dec 20227:00 amRNSUpdate on financial reporting
7th Dec 20226:00 pmRNSDirector/PDMR Shareholding
7th Dec 202210:12 amRNSNotice of AGM
6th Dec 20226:13 pmRNSDirector/PDMR Shareholding
6th Dec 20225:23 pmRNSDirector/PDMR Shareholding
6th Dec 202210:25 amRNSBlock listing Interim Review
1st Dec 202211:03 amRNSAnnual Financial Report
30th Nov 20222:00 pmRNSTotal Voting Rights
24th Nov 202210:00 amRNSNon-executive Director Appointment
18th Nov 20229:13 amRNSDirector/PDMR Shareholding
16th Nov 20227:00 amRNSResults for the year ended 30 September 2022
15th Nov 20227:00 amRNSNon-executive Director Appointment
31st Oct 20223:00 pmRNSTotal Voting Rights
30th Sep 202211:45 amRNSTotal Voting Rights
20th Sep 20227:00 amRNSInvestor and Analyst Event
31st Aug 20223:44 pmRNSTotal Voting Rights
30th Aug 20225:10 pmRNSSage completes Lockstep acquisition
24th Aug 20223:37 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.